Scleroderma Panel Test sale cost 490 AED
Acetylcholine Receptor ACHR Binding Antibody Test sale cost 510 AED Acetylcholine Receptor ACHR Binding Antibody Test Cost 570 د.إ Original price was: 570 د.إ.510 د.إCurrent price is: 510 د.إ.
Immune Deficiency Panel 3 CD3 Count Test sale cost 480 AED Immune Deficiency Panel 3 CD3 Count Test Cost 530 د.إ Original price was: 530 د.إ.480 د.إCurrent price is: 480 د.إ.
Sale!

Scleroderma Panel Test Cost

Original price was: 550 د.إ.Current price is: 490 د.إ.

-11%

The Scleroderma Panel Test is a diagnostic tool used to help detect the presence of scleroderma, a group of autoimmune diseases that cause hardening and tightening of the skin and connective tissues. This panel typically includes a series of blood tests that look for specific antibodies associated with scleroderma, such as antinuclear antibodies (ANA), anti-Scl-70, and anti-centromere antibodies. These antibodies are markers that can indicate an autoimmune process in the body and help in diagnosing scleroderma and distinguishing it from other autoimmune disorders.

At DNA Labs UAE, the Scleroderma Panel Test is offered for 490 AED. The test is conducted in a state-of-the-art laboratory setting by experienced professionals. DNA Labs UAE is known for its commitment to providing accurate, reliable, and timely diagnostic services. The test process involves collecting a blood sample from the patient, which is then analyzed using advanced laboratory techniques to detect the presence of scleroderma-related antibodies.

After the test, a detailed report is provided to the patient or the referring physician, which plays a crucial role in the diagnosis and management of scleroderma. Early detection through the Scleroderma Panel Test can significantly impact the treatment approach, potentially improving the quality of life for those affected by this condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SCLERODERMA PANEL Test

Test Cost: AED 490.0

Symptoms, Diagnosis, and Test Details

At DNA Labs UAE, we offer the SCLERODERMA PANEL Test to help diagnose and monitor the progression of scleroderma, a chronic autoimmune disease that affects the skin and connective tissues.

Test Components

  • Scl-70
  • Centromere Antibody

Price: 490.0 AED

Sample Condition

3 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery

Sample collected on Tue / Fri by 9 am will receive the report on the same day.

Method

The SCLERODERMA PANEL Test is performed using Enzyme Immunoassay.

Test Type

This test is used for the diagnosis of autoimmune disorders.

Doctor

This test is conducted by a Rheumatologist.

Test Department

The SCLERODERMA PANEL Test is conducted in the Genetic Lab.

Pre Test Information

No special preparation is required before undergoing this test.

Test Details

The SCLERODERMA PANEL Test is a blood test that helps in the diagnosis and monitoring of scleroderma. Scleroderma is a chronic autoimmune disease that affects the skin and connective tissues. The panel includes specific antibodies commonly found in individuals with scleroderma, such as anti-centromere antibodies (ACA), anti-topoisomerase I antibodies (Scl-70), anti-RNA polymerase III antibodies, and anti-U3 RNP antibodies. These antibodies are produced by the immune system in response to abnormal activation of certain cells and proteins in the body, which is characteristic of scleroderma.

The presence and levels of these antibodies in the blood can help healthcare providers in making a diagnosis and determining the subtype of scleroderma a person may have. The SCLERODERMA PANEL Test is usually ordered when a person presents with symptoms suggestive of scleroderma, such as thickening and hardening of the skin, joint pain and stiffness, Raynaud’s phenomenon (discoloration of fingers and toes in response to cold), and internal organ involvement. It may also be used to monitor disease activity and response to treatment.

It’s important to note that while the SCLERODERMA PANEL Test can provide valuable information, it is not a definitive diagnostic test for scleroderma. A diagnosis is typically made based on a combination of clinical symptoms, physical examination findings, and other diagnostic tests, such as skin biopsy, lung function tests, and imaging studies.

Overall, the SCLERODERMA PANEL Test is a useful tool in the evaluation and management of individuals suspected of having scleroderma, providing additional information to aid in diagnosis and treatment decisions.

Test Name SCLERODERMA PANEL Test
Components *Scl-70 *CentromereAntibody
Price 490.0 AED
Sample Condition 3 mL (1 mL min.) serum from 1 SST. Shiprefrigeratedorfrozen.
Report Delivery Sample Tue / Fri by 9 am; Report Same day
Method Enzyme Immunoassay
Test type Autoimmune disorders
Doctor Rheumatologist
Test Department:
Pre Test Information No special preparation required
Test Details

The Scleroderma Panel test is a blood test used to help diagnose and monitor the progression of scleroderma, a chronic autoimmune disease that affects the skin and connective tissues. The panel typically includes several specific antibodies that are commonly found in individuals with scleroderma, including anti-centromere antibodies (ACA), anti-topoisomerase I antibodies (Scl-70), anti-RNA polymerase III antibodies, and anti-U3 RNP antibodies.

These antibodies are produced by the immune system in response to the abnormal activation of certain cells and proteins in the body, which is characteristic of scleroderma. The presence and levels of these antibodies in the blood can help healthcare providers in making a diagnosis and determining the subtype of scleroderma a person may have.

The Scleroderma Panel test is usually ordered when a person presents with symptoms suggestive of scleroderma, such as thickening and hardening of the skin, joint pain and stiffness, Raynaud’s phenomenon (discoloration of fingers and toes in response to cold), and internal organ involvement. It may also be used to monitor disease activity and response to treatment.

It’s important to note that while the Scleroderma Panel test can provide valuable information, it is not a definitive diagnostic test for scleroderma. A diagnosis is typically made based on a combination of clinical symptoms, physical examination findings, and other diagnostic tests, such as skin biopsy, lung function tests, and imaging studies.

Overall, the Scleroderma Panel test is a useful tool in the evaluation and management of individuals suspected of having scleroderma, providing additional information to aid in diagnosis and treatment decisions.

SKU: TEST-6322 Category:

Related products